Skinvisible, Inc.
SKVI
$0.1763
$0.00714.20%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | -29.59% | 60.24% | |||
| Depreciation & Amortization | -3.92% | -13.56% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.87% | 56.69% | |||
| Operating Income | 29.59% | -58.96% | |||
| Income Before Tax | -189.26% | 209.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -189.26% | 209.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -189.26% | 209.84% | |||
| EBIT | 29.59% | -58.96% | |||
| EBITDA | 30.36% | -62.77% | |||
| EPS Basic | -210.32% | 175.28% | |||
| Normalized Basic EPS | 9.42% | 8.61% | |||
| EPS Diluted | -213.42% | 173.22% | |||
| Normalized Diluted EPS | 9.42% | 8.61% | |||
| Average Basic Shares Outstanding | -19.06% | 45.95% | |||
| Average Diluted Shares Outstanding | -19.06% | 45.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||